Membrane proteomics has emerged as a tool to study carbapenem resistance in Acinetobacter baumannii

Journal of Proteomics and Bioinformatics

Volumn 7, Issue 3, 2014, Pages

  Tiwari, Vishvanath ^a  

^a CENTRAL UNIVERSITY OF RAJASTHAN   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; COLISTIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIAL SURVIVAL; BIOFILM; EDITORIAL; HUMAN; MEMBRANE PROTEOMICS; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS;

EID: 84897472180     PISSN: None     EISSN: 0974276X     Source Type: Journal    
DOI: 10.4172/jpb.10000e26     Document Type: Editorial

References (27)

1. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, et al. (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48: 1-12.
2. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, et al. (2006) Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 42: 389-391.
3. Boucher HW, Corey GR (2008) Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46 Suppl 5: S344-349.
4. Davis KA, Moran KA, McAllister CK, Gray PJ (2005) Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 11: 1218-1224.
5. Camp C, Tatum OL (2010) A Review of Acinetobacter baumannii as a highly successful pathogen in times of war. Lab Med 41: 649-657.
6. Kempf M, Rolain JM, Diatta G, Azza S, Samb B, et al. (2012) Carbapenem resistance and Acinetobacter baumannii in Senegal: the paradigm of a common phenomenon in natural reservoirs. PLoS One 7: e39495.
7. Navon-Venezia S, Ben-Ami R, Carmeli Y (2005) Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 18: 306-313.
8. Bergogne-Bérézin E, Towner KJ (1996) Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9: 148-165.
9. Tiwari V, Kapil A, Moganty RR (2012) Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India. Microb Pathog 53: 81-86.
10. Hawkey PM, Jones AM (2009) The changing epidemiology of resistance. J Antimicrob Chemother 64 Suppl 1: i3-10.
11. Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, et al. (2010) Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 50: 1611-1616.
12. 2-lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics. J Mol Model 18: 3351-3361.
13. Tiwari V, Vashistt J, Kapil A, Moganty RR (2012) Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain. PLoS One 7: e39451.
14. Tan S, Tan HT, Chung MC (2008) Membrane proteins and membrane proteomics. Proteomics 8: 3924-3932.
15. Santoni V, Molloy M, Rabilloud T (2000) Membrane proteins and proteomics: un amour impossible? Electrophoresis 21: 1054-1070.
16. Martí S, Sánchez-Céspedes J, Oliveira E, Bellido D, Giralt E, et al. (2006) Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii. Proteomics 6 Suppl 1: S82-87.
17. Siroy A, Cosette P, Seyer D, Lemaître-Guillier C, Vallenet D, et al. (2006) Global comparison of the membrane subproteomes between a multidrugresistant Acinetobacter baumannii strain and a reference strain. J Proteome Res 5: 3385-3398.
18. Fernández-Reyes M, Rodríguez-Falcón M, Chiva C, Pachón J, Andreu D, et al. (2009) The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective. Proteomics 9: 1632-1645.
19. Soares NC, Cabral MP, Parreira JR, Gayoso C, Barba MJ, et al. (2009) 2-DE analysis indicates that Acinetobacter baumannii displays a robust and versatile metabolism. Proteome Sci 7: 37.
20. Kwon SO, Gho YS, Lee JC, Kim SI (2009) Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol Lett 297: 150-156.
21. Mazzoli R, Fattori P, Lamberti C, Giuffrida MG, Zapponi M, et al. (2011) High isoelectric point sub-proteome analysis of Acinetobacter radioresistens S13 reveals envelope stress responses induced by aromatic compounds. Mol Biosyst 7: 598-607.
22. Cabral MP, Soares NC, Aranda J, Parreira JR, Rumbo C, et al. (2011) Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism. J Proteome Res 10: 3399-3417.
23. Yun SH, Choi CW, Kwon SO, Park GW, Cho K, et al. (2011) Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrugresistant Acinetobacter baumannii. J Proteome Res 10: 459-469.
24. Lee H, Chenb C, Wangb S, Sud L, Chenb S, et al (2011) Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. Int J Antimicrob Agents 37: 302-308.
25. Vashist J, Tiwari V, Kapil A, Rajeswari MR (2010) Quantitative profiling and identification of outer membrane proteins of beta-lactam resistant strain of Acinetobacter baumannii. J Proteome Res 9: 1121-1128.
26. Nwugo CC, Gaddy JA, Zimbler DL, Actis LA (2011) Deciphering the iron response in Acinetobacter baumannii: A proteomics approach. J Proteomics 74: 44-58.
27. Tiwari V, Moganty RR (2013) Effect of iron availability on the survival of carbapenem-resistant Acinetobacter baumannii: a proteomic approach. J Proteomics Bioinform 6: 125-131.